Patchd - Prediction of Sepsis in a High-Risk Post-Acute Care Population

Purpose of this Study

We are doing this study to evaluate the performance of an experimental medical technology called the Patched Sepsis Prediction Algorithm (the study technology). This technology is designed to detect the early signs of sepsis and give clinicians the chance to treat it earlier than usual.

Who Can Participate?

Eligibility

Adults who:

Are scheduled to receive, are actively receiving, or have recently received (within the past 7 days) cytotoxic chemotherapy and/or bone marrow transplantation
Are diagnosed with a hematologic malignancy
Are capable of using vitals-sign monitoring equipment and smartphone applications or have access to assistance for their use
Own an Android or iOS smartphone
Do not have uncontrolled arrhythmia, a cardiac pacemaker or a left ventricular assist device

For more information about who can join this study, please contact the study team at terri.lucas@duke.edu or 919-681-6580.

What is Involved?

Description

If you choose to join this study, you will go through a screening/training visit. During this screening/training/visit, you will:

Answer questionnaires
Learn how to use the study technology

During the study, you will wear continuous vital-sign monitoring equipment for the study monitoring period. The study kit will be provided to recruited patients following discharge from the hospital or in outpatient clinic after chemotherapy and will be worn for the entire monitoring period. The system will not be set up to trigger any alerts, only to collect data. Your participation in the study will last for up to 90 days.

Study Details

Full Title

Patchd - Prediction of Sepsis in a High-Risk Post-Acute Care Population

Principal Investigator

Lindsay

Rein

Protocol Number

PRO00112372

Phase

Enrollment Status

Pending Open to Enrollment